B-Cell-Activating Factor and Autoimmune Myasthenia Gravis

Joint Authors

Ragheb, Samia
Lisak, Robert P.

Source

Autoimmune Diseases

Issue

Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-10, 10 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2011-11-28

Country of Publication

Egypt

No. of Pages

10

Main Subjects

Diseases

Abstract EN

BAFF is a potent B-cell survival factor, and it plays an essential role in B-cell homeostasis and B-cell function in the periphery.

Both normal and autoreactive B cells are BAFF dependent; however, excess BAFF promotes the survival, growth, and maturation of autoreactive B cells.

When overexpressed, BAFF protects B cells from apoptosis, thereby contributing to autoimmunity.

Three independent studies have shown higher BAFF levels in the circulation of MG patients.

BAFF may play an important role in the pathogenesis of MG.

BAFF antagonists may well provide new treatment options for MG patients, particularly those patients with thymic lymphoid follicular hyperplasia.

American Psychological Association (APA)

Ragheb, Samia& Lisak, Robert P.. 2011. B-Cell-Activating Factor and Autoimmune Myasthenia Gravis. Autoimmune Diseases،Vol. 2011, no. 2011, pp.1-10.
https://search.emarefa.net/detail/BIM-509839

Modern Language Association (MLA)

Ragheb, Samia& Lisak, Robert P.. B-Cell-Activating Factor and Autoimmune Myasthenia Gravis. Autoimmune Diseases No. 2011 (2011), pp.1-10.
https://search.emarefa.net/detail/BIM-509839

American Medical Association (AMA)

Ragheb, Samia& Lisak, Robert P.. B-Cell-Activating Factor and Autoimmune Myasthenia Gravis. Autoimmune Diseases. 2011. Vol. 2011, no. 2011, pp.1-10.
https://search.emarefa.net/detail/BIM-509839

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-509839